HCID 86723936, compound → HCID 86723935, compound
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][C@H:12]([CH2:14][CH3:15])[N:11]([CH2:16][C:17]([O:19]CC2C=CC=CC=2)=[O:18])[CH2:10][C@H:9]1[CH3:27])=[O:7])([CH3:4])([CH3:3])[CH3:2]>CO.[Pd]>[C:1]([O:5][C:6]([N:8]1[CH2:13][C@H:12]([CH2:14][CH3:15])[N:11]([CH2:16][C:17]([OH:19])=[O:18])[CH2:10][C@H:9]1[CH3:27])=[O:7])([CH3:2])([CH3:3])[CH3:4]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
Pd/C (10%, 810 mg) was added to a solution of (2R,5S)-4-benzyloxycarbonylmethyl-5-ethyl-2-methyl-piperazine-1-carboxylic acid tert-butyl ester (2.8 g, 7.6 mmol) in MeOH (50 mL). The suspension was stirred overnight under H2. and catalyst was removed via filtration through Celite and the filtrate was evaporated in vacuo to give the title compound (1.7 g) as a pale yellow solid. 1H NMR (DMSO-d6): 4.41-3.89 (1H, m), 3.89-3.64 (1H, m), 3.37-3.21 (1H, m), 3.21-3.05 (2H, m), 2.71-2.55 (2H, m), 2.54-2.42 (3H, m), 1.45-1.36 (9H, m), 1.16 (3H, d), 0.83 (3H, t). MS: [M+H]+=287.
Workup
- customand catalyst was removed via filtration through Celite
- customthe filtrate was evaporated in vacuo
Sources & evidence
- ORD record
- ord-c9104f2108574f53a958b173f5025dcd
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09018214B2
Reaction notes
Loading…